Loss of glutamine synthetase (GS) in hippocampal astrocytes has been implicated in the causation of human mesial temporal lobe epilepsy (MTLE). However, the mechanism by which the deficiency in GS leads to epilepsy is incompletely understood. Here we ask how hippocampal GS inhibition affects seizure phenotype and neuronal activation during epilepsy development (epileptogenesis). Epileptogenesis was induced by infusing the irreversible GS blocker methionine sulfoximine (MSO) unilaterally into the hippocampal formation of rats. We then used continuous video-intracranial electroencephalogram (EEG) monitoring and c-Fos immunohistochemistry to determine the type of seizures and spatial distribution of neuronal activation early (1-5 days postinfusion) and late (16-43 days postinfusion) in epileptogenesis. Early in epileptogenesis, seizures were preferentially mild (stage 1-2), activating neurons in the entorhinal-hippocampal area, the basolateral amygdala, the piriform cortex, the midline thalamus, and the anterior olfactory area. Late in epileptogenesis, the seizures were generally more severe (stages 4-5) with neuronal activation extending to the neocortex, the bed nucleus of the stria terminalis, the mediodorsal thalamu\s, and the central nucleus of the amygdala. Our findings demonstrate that inhibition of GS focally in the hippocampal formation triggers a process of epileptogenesis characterized by gradual worsening of seizure severity and involvement of progressively larger neuronal populations over a period of several weeks. Knowledge about the underlying mechanism of epileptogenesis is important because such knowledge may result in more specific and efficacious treatments of MTLE by moving away from large and poorly specific surgical resections to highly targeted surgical or pharmacological interventions of the epileptogenic process.
Introduction
Mesial temporal lobe epilepsy (MTLE) is one of the most common types of medication refractory epilepsies. For up to one-third of patients with MTLE, current antiepileptic drugs do not adequately control seizures, or cause side effects that limit their use. Because the seizures are thought to originate from mesial (i.e. limbic) structures within the medial temporal lobe -particularly the hippocampal formation, entorhinal cortex and amygdala -unilateral resection of these structures along with adjacent white matter tracts and neocortical areas has remained the standard of care for medication refractory MTLE for over half a century (Falconer and Taylor, 1968; Spencer et al., 1984) . While such surgery leads to short-term cessation of seizures in N 75% of cases, the procedure can result in complications and adverse outcomes (Hader et al., 2013) . Moreover, the seizures will eventually recur in approximately 50% of patients who become seizure free after surgery (Foldvary et al., 2000; Jeha et al., 2006; Yoon et al., 2003) , suggesting that the causative mechanism of MTLE is not removed by current neurosurgical approaches, but remains latent elsewhere in the brain. Knowledge about the causative mechanism of epilepsy is important because such knowledge is expected to result in more specific and efficacious treatments of MTLE.
There is increasing evidence to suggest that the enzyme glutamine synthetase (GS) is implicated in the causation of epilepsy. GS is deficient in hippocampal astrocytes in patients with medication refractory MTLE (Eid et al., 2004; van der Hel et al., 2005) and in astrocytes in the amygdala in patients with neocortical epilepsies (Steffens et al., 2005) . Because GS is necessary for the conversion of glutamate and ammonia to glutamine, its deficiency is expected to cause an increase in glutamate and ammonia in astrocytes lacking the enzyme. It is possible that the high levels of glutamate and ammonia in astrocytes can enter the extracellular compartment of the brain via several mechanisms and lead to Experimental Neurology 288 (2017) [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] seizures, oxidative/nitrosative stress, inflammation, and cellular injury (Bezzi et al., 1998; Danbolt, 2001; Olney et al., 1972; Robert et al., 2015; Tian et al., 2005) .
We have previously shown that inhibiting GS by chronic infusion of the irreversible enzyme blocker methionine sulfoximine (MSO) into the hippocampal formation or amygdala of rats, leads to a sequence of events similar to those experienced by some patients with MTLE. I.e. an initial episode of prolonged, low-grade seizures; a clinically silent latent period; and eventually, recurrent seizures that increase in severity as the disease evolves over time. The MSO-treated animals recapitulate many other features of human MTLE such as perturbations in the homeostasis of neurotransmitter glutamate, loss of hippocampal neurons, changes in monocarboxylate transporters, and comorbid depressive features (Eid et al., 2008; Gruenbaum et al., 2015; Lauritzen et al., 2012) . We now use c-Fos staining in the MSO-model of MTLE to assess how hippocampal GS inhibition affects neuronal activation during epileptogenesis. Our working hypothesis is that epileptogenesis caused by hippocampal GS inhibition is characterized by activation of progressively larger neuronal populations over a period of weeks, suggestive of a process of evolving neuronal plasticity.
Materials and methods

Chemicals and animals
All chemicals were obtained from Sigma Chemical Co. (St. Louis, Mo.) unless otherwise noted. Male Sprague Dawley rats were used in this study (200 to 250 g; Charles River Laboratories, Wilmington, Mass.). Rats had free access to food and water and were housed on a 12 h/12 h light/dark cycle, with lights on from 7 a.m. to 7 p.m. The animal care and use procedures were approved by the Institutional Animal Care and Use Committee of Yale University. All experiments were performed in accordance with current guidelines.
Intrahippocampal infusion of MSO or PBS
Nineteen rats were anesthetized with 1% to 2% Isoflurane (Baxter, Deerfield, Ill.) in O 2 and placed in a stereotaxic frame (David Kopf Instruments, Tujunga, Calif.) . A 30-gauge stainless steel cannula attached to a plastic pedestal (Plastics One, Roanoke, Va.) was introduced through a burr hole in the skull and into the right hippocampus, using the following coordinates with bregma as the reference: AP = − 5.6 mm, ML = 5.3 mm, DV = − 6.5 mm. The cannula was cemented to the skull using cyanoacrylate and connected via plastic tubing to a subcutaneously implanted Alzet osmotic pump (Model 2004, Durect Corp., Cupertino, Calif.) . This pump holds a total volume of 200 μL and delivers a continuous flow of 0.25 μL/h for ∼28 days (as per manufacturer's specifications). One set of pumps was filled with MSO (2.5 mg/mL; dissolved in Dulbecco's Phosphate Buffered Saline, PBS) to achieve a delivery of 0.625 μg of MSO per h (n = 10). Another set of pumps was filled with PBS and implanted in control animals (n = 9). Rats were operated on sequentially in 10 pairs of 2, each pair consisting of an MSO injected rat and a matched PBS control such that treatment and timing of fixation in relation to surgery could be maximally approximated in the control.
Four stainless steel epidural screw electrodes (Plastics One) were implanted to record cortical electroencephalogram (EEG) activity. Two electrodes (one in each hemisphere) were positioned in the epidural space overlying the parietal neocortex. A third electrode was positioned in the epidural space near lambda to serve as the reference. A fourth electrode was positioned over the occipital bone (not touching the dura) to serve as the ground. The female socket contacts on the end of each electrode were inserted into a plastic pedestal (Plastics One), and the entire implantation was secured by UV light cured acrylated urethane adhesive (Loctite 3106 Light Cure Adhesive, Henkel Corp., Rocky Hill, Conn.).
Video-intracranial EEG monitoring and seizure quantitation
The experimental setup for recording video-EEG was adapted from Bertram (2006) . The rats were placed individually in custom-made Plexiglas cages. A spring-covered, 6-channel cable was connected to the electrode pedestal on one end and to a commutator (Plastics One) on the other. A second cable connected the commutator to the digital EEG recording unit (CEEGraph Vision LTM, Natus Bio-logic Systems Corp., Mundelein, Ill.). Digital cameras with infrared light detection capacity were used to record animal behavior (two cages per camera). The digital video signal was encoded and synchronized to the digital EEG signals. Seizures were identified by visual inspection of the EEG record. As detailed in Avoli and Gloor (1994) seizures were defined by EEG characteristics and not by the duration of the discharge. Specifically, seizures displayed distinct signal changes from background (interictal) activity. Such signal changes included sustained rhythmic or spiking EEG patters and a clear evolution of signal characteristics from onset to termination.
As timing of fixation following seizures was critical to the c-Fos staining method described below, the rats were followed in real time by a researcher blinded to their condition (MSO or PBS). Eight rats were monitored at a time, always consisting of 4 MSO rats paired with their matched PBS control. One set of MSO and PBS rats was monitored during the first five days of MSO infusion (early epileptogenesis group), and another set was monitored during days 15 to 43 after MSO infusion (late epileptogenesis group). When seizure activity was observed on the EEG and by monitoring rat behavior by the blinded researcher in real time, the time of the seizure was noted, and a second researcher immediately reviewed the video-EEG recordings to independently confirm the occurrence of, and stage of the seizure. The seizures were staged by behavioral analysis using a modification of Racine's criteria (Racine et al., 1973) , as follows: stage I, immobilization, eye blinking, twitching of vibrissae and mouth movements; stage II, head nodding, often accompanied by facial clonus; stage III, forelimb clonus; stage IV, rearing; stage V, rearing, falling and generalized convulsions. The MSO seizure rat and its matched PBS control were transported together from the monitoring room to the main lab 45 min following the seizure for perfusion fixation, which occurred 1 h after the onset of the seizure.
Pilocarpine control
In order to confirm the efficacy of the c-Fos staining protocol, 1 rat was injected subcutaneously with 325 mg/kg pilocarpine dissolved in PBS. Within a few hours of injection several stage V seizures occurred. One hour after the onset of the first stage V seizure the rat was perfusion fixed and processed for c-Fos staining following the same protocol as for MSO/PBS infused rats.
Tissue preparation, immunohistochemistry and nomenclature
At 1 h after the observed seizure, the MSO seizure rat and its matched PBS control were anesthetized with Isoflurane and perfused transcardially with saline followed by 4% formaldehyde in phosphate buffer (PB; 0.1 M, pH 7.4). The brains were removed and left in the same fixative overnight at 4°C and then transferred to 20% sucrose (dissolved in PB) the next day. After at least 24 h in 20% sucrose, the brains were sectioned horizontally on a sliding microtome at 50-μm thickness. Every fifth section was mounted on gelatin-coated slides and stained with cresyl violet. The remaining four sets of sections were stored in FD Tissue Cryoprotection Solution (FD Neurotechnologies, Columbia, Md.) at − 20°C prior to staining. These sectioned brains were logged and randomly coded by one researcher in order to blind a second researcher to the condition of the rats. Blinding the primary researcher to both the condition (MSO, PBS, pilocarpine) and to the stage of seizure (stage 1 or stage 5) was critical due to the descriptive and subjective nature of the analysis.
Staining with c-Fos was performed after completion of all seizure monitoring and brain sectioning on a total of 20 rats (10 MSO, 9 PBS, 1 pilocarpine). All of the following steps were performed at room temperature using a shaker on a low setting for continuous, but gentle mixing. Brain sections were removed from −20°C and washed in fresh PBS solution for 5 min, 3 times. Membranes were then permeabilized with a wash in 0.3% Triton-X-100 in 0.1 M PB for 30 min, followed by 3 washes in PBS of 5 min each. Brain sections were then transferred to 1 M ethanolamine in 0.1 M PB for 30 min to quench aldehydes, followed again by 3 washes in PBS of 5 min each. The sections were next transferred to 4% dry milk in PBS for blocking. After 1 h in the dry milk, the primary antibody, rabbit anti-c-Fos IgG was added at a dilution of 1: 10,000, the dish was sealed with parafilm, and left overnight on the shaker. The following day, the sections were first washed in fresh PBS for 1 min, followed by 3 consecutive 20 min washes. Next, they were moved to secondary biotinylated anti-rabbit IgG antibody from a Vectastain Elite kit (Vector Laboratories, Burlingame, Calif.) diluted as instructed to 0.05% in PBS. The sections were then washed in fresh PBS for 1 min, followed by 3 consecutive 15 min washes. Next, the sections were transferred to the Vectastain A + B solution mixed at a ratio of 1 drop per 5 mL PBS, which was allowed to stand for at least 30 min prior to use. The sections were then washed again in fresh PBS for 1 min followed by 3 consecutive 10 min washes. Finally, the staining reaction was developed by transferring the sections to 0.05% DAB, 0.009% H 2 O 2 in PBS. Sections were initially monitored carefully for development, periodically checking the progress under the microscope. Ultimately it was decided that 15 min was the optimal time. After 15 min in this solution, the sections were washed in 0.1 M PB for 10 min, 3 consecutive times. Sections were then carefully mounted on gelatin-coated slides using 0.1 M PB and allowed to dry overnight before they were covered and logged for analysis under the microscope.
The slides were covered and examined under a light microscope. The subdivisions of the hippocampus are in accordance with the work of Lorente de Nó (Lorente de Nó, 1934) with the modifications suggested by Amaral and Insausti (Amaral and Insausti, 1990) . In brief, the hippocampus is divided into (a) the subiculum, (b) the Ammon's horn (hippocampus proper), which comprises fields CA1-3, and (c) the dentate gyrus, which includes the molecular layer, granule cell layer, and polymorphic layer of the hilus.
Analysis and grading protocol
Four treatment groups were analyzed (Table 1) : MSO injection Racine stage 1 seizure/early epileptogenesis (n = 7), MSO injection Racine stage 5 seizure/late epileptogenesis (n = 3), PBS injection negative control (n = 9), and pilocarpine Racine stage 5 seizure positive staining control (n = 1). The researcher performing the analysis remained blinded to the condition of the rats. First the sections stained at 1:10,000 primary antibody dilutions were observed generally. Of the 20 rats under analysis, 11 were found to have grossly apparent staining of varying extent at 4× magnification, and 9 were found to have nearly absent staining at 4 × magnification. These were then re-examined at 10× magnification and it was determined that these 9 rats had no staining of significance. It was also determined at this time that the staining of the 11 rats, while grossly apparent, was suboptimal in terms of intensity. It was decided to repeat the above staining procedure with two minor changes as described. This was done on the 11 rats with apparent staining and 1 selected rat of the 9 without apparent staining from the original protocol. The researcher performing the staining and analysis remained blinded to the condition of the selected rats.
The 1:2500 dilution c-Fos stained sections from the 12 rats were generally observed and a semi-quantitative grading scale was devised to summarize the findings. The sections were analyzed sequentially, using the Paxinos Rat Brain Atlas as a reference (Paxinos and Watson, 2006) , first to identify the approximate dorso-ventral level of the horizontal section, then to grade nuclear c-Fos staining in the various regions/nuclei. One hundred and nine different regions/nuclei were considered independently, including 27 regions of the hippocampus and cortex, which were considered separately on the ipsilateral and contralateral hemispheres relative to the injection site. Fifty-five subcortical regions were considered bilaterally, but differences in staining of between ipsilateral and contralateral side were noted. It was attempted to consider as much detail as possible, but some nuclei had to be grouped (for example the subnuclei related to the stria terminalis) due to an inability to resolve any finer detail after considering all available anatomical clues to orientation.
Staining in each region was graded in terms of both density (number of cells per unit area) and intensity (darkness of the coloring within each cell; Fig. 1 ). Density was graded on a stepwise scale from 0.5 to Table 1 Log of animals and the observed seizures under study. MSO-infused rats and matched PBS-infused controls were perfusion fixed with formaldehyde about 1 h after the observed seizure. The brains were then serial sectioned into 5 sets of evenly spaced 50 μm sections. One set was stained with cresyl violet for anatomic reference. All brains were stained with c-Fos. 2.5, with 0.5 representing the highest density and 2.5 the highest density staining observed. Intensity was graded on a similar scale from 0.5 to 2.5, with 0.5 representing c-Fos visible just above the background staining and 2.5 representing extremely intense staining. Finally, the scores for intensity and density were added to a single score, ranging from 1 (lowest density and intensity observed) to 5 (highest density and intensity observed). The scores are listed in Tables 2A and 2B and color coded according to their magnitude. It was recognized that this method of analysis is subjective and would likely not be perfectly replicable with a different researcher doing the analysis. The goal was not to rigorously quantitate the level of c-Fos staining, but rather to assess the relative activation of various areas of the brain during seizures, and how these networks of activation change and develop with development from stage 1 to stage 5 seizures. The combined density and intensity scores for the 7 early and 3 late stage animals were compared using a two-sided MannWhitney U test, separately for each of the areas studied. The areas which were significantly different (p b 0.05) were reported. A correction for multiple comparisons was not performed for this exploratory data analysis.
Results
MSO infusion location, seizures and neuronal loss
The MSO injection was targeted at the right entorhinal-hippocampal area (i.e. subiculum, deep entorhinal cortex and angular bundle) in the right, or hereafter, "ipsilateral" hemisphere (Table 1 , asterisks in Fig. 2 ), and only rats with infusions into this area were included in the study. We have shown previously that targeting these areas result in a similar pattern of recurrent seizures that evolve in frequency and behavioral severity over a period of several weeks, consistent with a process of epileptogenesis . The MSO-and PBS-infused rats exhibited variable degrees of nonselective neuronal loss in a zone surrounding the infusion track. The loss was minimal in the PBS-infused rats, extending up to 100 μm from the center of the track. In the MSO-infused rats, the loss was minimal to moderate, consistent with prior studies (Eid et al., 2008) , extending in some cases as far as 500 μm from the center of the track. The areas of neuronal loss were excluded from the c-Fos staining assessment.
The entorhinal-hippocampal area and neocortex
Due to the location of the MSO infusion, it was expected that significant seizure-induced staining would be observed in this region, particularly in highly interconnected areas. While some variation in staining patterns between rats was observed in most brain regions, the staining in the ipsilateral hippocampus was remarkably reproducible with consistent and strong/dense staining of neurons in the dentate granular layer and the pyramidal cell layers of the CA fields (Table 2A , Fig. 2C ). While the polymorphic layer of the dentate hilus showed less dense packing of stained cells, each cell's staining intensity was remarkably high (Table 2A , Fig. 2C ). The subiculum showed some variation depending on the depth, with superficial areas (juxtaposed to the dentate) staining similarly to CA1 and deeper layers (adjacent to the angular bundle) exhibiting weaker and less dense staining. Far weaker staining was observed inconsistently in the strata radiatum, lucidum, and oriens of the CA fields (Fig. 2C) , and the molecular layer of the dentate remained almost completely devoid of staining (Fig. 2C) . Furthermore, this same staining pattern in the hippocampus remained consistent, not only in early (Fig. 2C ) and late epileptogenesis (Fig. 2C) ipsilaterally, but also early (Fig. 2B, H) and late ( Fig. 2A, E) in the contralateral hemisphere.
Beyond the hippocampus proper, increased variation in staining was observed, and a common pattern that will be repeated in the subsequent sections emerged. Despite the unilateral injection, c-Fos staining was most commonly bilateral, as in the hippocampus. However, a handful of regions were stained only ipsilaterally in early epileptogenesis, but staining extended bilaterally in MSO late epileptogenesis. The first examples of this pattern of ipsilateral concordance and contralateral discordance between early and late seizures was observed in the parasubiculum (Fig. 2F, I ) and entorhinal cortex (Fig. 2 G, J) . Although the MSO infusion targeted the deep layers of the entorhinal cortex, it was the superficial layers that showed somewhat stronger staining on the ipsilateral side during early and late epileptogenesis (Fig. 2C, D) . The parasubiculum also showed significant staining ipsilaterally during Grading and color coding. C-Fos staining was graded on two independent scales, 0.5 to 2.5 for the density (number of stained cells/unit area) and 0.5 to 2.5 for intensity (darkness of staining/cell) in all analyzed brain regions. Examples of density scoring are shown in red font and of intensity scoring in black font. The numbers for density and intensity were added to provide single scores, which were plotted in Tables 2A and 2B. early and late epileptogenesis (Fig. 2C, D) . However, contralateral superficial entorhinal and parasubiculum staining was less dense and deep entorhinal staining disappeared altogether during early epileptogenesis ( Fig. 2 G, J) . While the contralateral parasubiculum was densely stained during late epileptogenesis (Fig. 2F ), no staining was apparent at the early stage (Fig. 2I) . The neocortex was consistently stained during early and late epileptogenesis with notable differences in staining patterns. In general, staining was restricted to the ipsilateral perirhinal, ectorhinal and temporal association cortex in early epileptogenesis (Fig. 2B, C, H) , whereas large portions of the neocortex were stained bilaterally in late epileptogenesis ( Fig. 2A, D, E) . The neocortical staining during late epileptogenesis was particularly pronounced in sensorimotor areas (Tables 2A and 2B ). This finding corroborates with the more severe, stage 5 motor seizures that were preferentially observed in the chronic stage rats. The nonepileptic PBS-infused control rats were negative or only very faintly stained for c-Fos staining in all of the above regions (Fig. 2K) .
Other cortical regions
Strong staining was observed in the anterior olfactory nucleus (Fig.  3A-E) , the olfactory cortex, the piriform cortex (Fig. 3A-E ) and the tenia tecta (Fig. 3A-E) in both early and late epileptogenesis. Similar to other regions, the staining was strong ipsilaterally (Fig. 3C, D) and weak or absent contralaterally early in epileptogenesis (Fig. 3B) , and strong bilaterally late in epileptogenesis (Fig. 3A) . Interestingly, despite their related function, the olfactory tubercle and navicular nucleus showed complete absence of staining in all MSO-infused rats (Tables  2A and 2B) . Table 2A C-Fos staining in the hippocampal formation and cortical regions. Seven rats from early epileptogenesis and three rats from late epileptogenesis are shown in columns A and B followed in column C by one representative PBS-treated negative control and one pilocarpine-treated positive control. Statistical comparisons between early epileptogenesis (A) and late epileptogenesis (B) are provided in the rightmost column. Only p-values b 0.05, with their corresponding brain areas highlighted in gray, are shown. Each region was independently graded for staining density (number of stained cells per unit area, scored 0.5-2.5) and intensity (darkness of stain within each cell, scored 0.5-2.5), and the grades for density and intensity were added to a single numerical score and color coded according to its magnitude (see also Fig. 1 ). For regions not explicitly shown bilaterally, differences in staining ipsilateral and contralateral to the injection are noted: *decreased staining contralateral vs. ipsilateral; **staining only observed ipsilateral to injection. The ipsilateral dorsal endopiriform nucleus, claustrum and agranular insular cortex were stained in a subset of the early stage rats (Fig. 3H, M) and in all of the late stage rats (Fig. 3I, N) . Except from a small patch of strongly stained cells in 2 of 3 rats with late/stage 5 seizures, the majority of neurons in the caudate putamen and globus pallidus were not consistently stained.
There was some variation in the staining of the various sub-regions of the amygdala, but staining was most consistently seen in the lateral nucleus, ipsilateral to MSO-infusion, in the majority of early (Fig. 3R ) and late stage (Fig. 3S) rats. While staining in the lateral nucleus was usually present in the contralateral amygdala in the late stage rats (Fig. 3P) , contralateral staining was usually absent in the early stage animals (Fig. 3Q) . Staining was also observed, but with less frequency, in the unilateral central nucleus and the amygdalostriatal transition area in the early and late stage rats. A similar staining pattern was also observed in the contralateral hemisphere in the late stage rats (Fig.  3P ) whereas staining was absent in the early stage rats (Fig. 3Q) . The nonepileptic PBS-infused control rats were negative or only very faintly stained for C-Fos staining in all of the above regions (Fig. 3E, J, O, T) .
The thalamus and hypothalamus
Perhaps one of the most notable and generalizable aspects was a lack of strong staining in most regions of the thalamus or hypothalamus in Table 2B C-Fos staining in the subcortical regions and the brainstem. Seven rats from early epileptogenesis and three rats from late epileptogenesis are shown in columns A and B followed in column C by one representative PBS-treated negative control and one pilocarpine-treated positive control. Statistical comparisons between early epileptogenesis (A) and late epileptogenesis (B) are provided in the rightmost column. Only p-values b 0.05, with their corresponding brain areas highlighted in gray, are shown. Each region was independently graded for staining density (number of stained cells per unit area, scored 0.5-2.5) and intensity (darkness of stain within each cell, scored 0.5-2.5), and the grades for density and intensity were added to a single numerical score and color coded according to its magnitude (see also Fig. 1 ). For regions not explicitly shown bilaterally, differences in staining ipsilateral and contralateral to the injection are noted: *decreased staining contralateral vs. ipsilateral; **staining only observed ipsilateral to injection. any of the MSO-infused rats. While some staining was present in these regions, it was weaker and less consistent than in most of the aforementioned areas. Weak to moderate staining was observed, though inconsistently, in the midline thalamic nuclei such as the interomediodorsal (Fig. 4A, B) , rhomboid, reuniens, and central medial (Fig. 4A, B , D, E, F, G). The only thalamic nuclei with staining observed in N4 of the 10 treatment rats was the central medial. While the paraventricular nuclei of the thalamus (Fig. 4A, B , D, E, F, G) and hypothalamus were consistently stained in the MSO-infused rats, both nuclei were stained in the PBS control rats (Fig. 4C, H, I ). Thus, the staining is probably not specific for seizures, but likely to be related to stress, such as change in environment in the hour between the seizure occurrence and fixation. Involvement of these nuclei in stress is consistent with previous studies (Benarroch, 2005) .
Other brain regions
Other areas of the brain and brainstem showed weak and inconsistent staining, such as the habenula, tectal/pretectal nucleus, periaqueductal gray and dorsal raphe nuclei (Tables 2A and 2B ). None of the above regions stained in PBS-infused rats; however, the following areas were labeled in both PBS-and MSO-infused rats, making their involvement in seizures less likely: the geniculate, lateral septal, and supramammilary nuclei (Tables 2A and 2B ).
Discussion
We have used the intrahippocampal MSO-infusion model of MTLE to demonstrate how increasing populations of neurons are activated by seizures as the disorder progresses over a period of several weeks. Our main finding is that seizure activation is preferential to selected limbic structures during early stages of the disorder, whereas involvement of more extensive brain areas occurs later in epileptogenesis. This finding supports our working hypothesis that epileptogenesis caused by unilateral hippocampal GS inhibition evolves over time, from a highly focal disorder to a pathological process of widespread neuronal network activation.
C-Fos and neuronal activation
Immediate early gene expression has been instrumental in identifying activated neurons in different brain regions. The prototypical and There is strong C-Fos staining of neurons in several regions ipsilateral to the MSO-infusion (asterisks) both early (C) and late (D) in epileptogenesis. Regions with particularly intense staining include granule cells (Gr) and polymorphic cells (Po) of the dentate gyrus (DG) as well as neurons in the CA1, subiculum (Sub), parasubiculum (PaS), and layers of the entorhinal cortex (EC) and temporal association cortex (TeA). In general, there is more extensive staining for c-Fos during late vs. early epileptogenesis ipsilateral to the MSO-infusion. Neurons in several areas contralateral to the MSO-infusion are stained as well with a marked increase in the number of stained cells late (A, E, F, G) vs. early (B, H, I, J) in epileptogenesis. In the contralateral hemisphere, numerous neurons are stained in the TeA, PaS, and layers V-VI of the EC during late epileptogenesis (E, F, G) whereas the corresponding areas show minimal if any staining during early epileptogenesis (H, I, J). A nonepileptic (PBS-infused) rat is shown in K [Rat C (pbs)] and is negative for c-Fos staining (K). Abbreviations: CA1-3, cornu ammonis subfields 1-3 of the hippocampus; LMol, stratum lacunosum-moleculare; Mol, molecular layer of the dentate gyrus; Or, stratum oriens; Pyr, pyramidal layer; Rad, stratum radiatum. most characterized immediate early gene-encoded transcription factor is c-Fos which is expressed with a peak of 30 to 90 min after stimulation (Herrera and Robertson, 1996) . There is ample literature describing neuronal c-Fos induction following kindling and other seizure models (Barone et al., 1993; Bozzi et al., 2011; Chiasson et al., 1995; Dragunow and Faull, 1989; Curran, 1991a, 1991b; Motte et al., 1997) . Furthermore, several studies have demonstrated a correlation between the expansion of cFos induction from limbic areas to the cerebral cortex and the progression of epileptic seizures (Andre et al., 1998; Clark et al., 1991; Ebert and Loscher, 1995; Hiscock et al., 2001; Simler et al., 1999; Szyndler et al., 2009; Willoughby et al., 1997) . These studies and others have capitalized on the following advantages of c-Fos as a marker of neuronal activity: ease of detection, good sensitivity following neuronal stimulation, cellular mapping that enables the examination of all neurons in a particular network spanning multiple brain regions, and the ability to combine c-Fos labeling with other immunohistochemical markers and/or retrograde axonal tracing for connectivity studies. Abundant neuronal staining is evident in the ventral tenia tecta (VTT) and anterior olfactory area, external part (AOE) ipsilateral to the infusion during early (C) and late (D) epileptogenesis. Contralateral to the infusion, staining is weaker during late epileptogenesis and absent during early epileptogenesis. F-I: Neurons in the piriform cortex (Pir), agranular insular cortex (AI) and dorsal endopiriform nucleus (Den) are strongly stained ipsilateral to the infusion during early epileptogenesis (H) and weakly stained during late epileptogenesis (I). Contralateral to the infusion, staining is weak during late epileptogenesis and absent during early epileptogenesis. K-O: There is abundant staining of neurons in the dorsal endopiriform nucleus (Den), central nucleus of the amygdala (Ce), and posterior part of the agranular insular cortex (AIP) ipsilateral to the infusion during early (M) and late (N) epileptogenesis. Contralateral to the infusion, staining is weak during late epileptogenesis (K) and absent during early epileptogenesis (L). P-S: Discrete nuclei in the amygdala are strongly stained ipsilateral to the infusion during early epileptogenesis (R), particularly the lateral (LA) and parts of the central (CeA) nuclei. The dorsal endopiriform nucleus (Den) and amygdalostriatal transition area (ASt) were stained as well. Staining in these areas was less pronounced ipsilateral (S) and contralateral (P) to the infusion during late epileptogenesis. Staining was absent ipsilateral to the infusion during early epileptogenesis (Q). There is complete absence of c-Fos staining in all areas shown in the PBS infused control rat (E-T). Abbreviations: aca, anterior commissure, anterior part; BLA, basolateral amygdaloid nucleus, anterior part; STIA, bed nucleus of the stria terminalis, intraamygdaloid division.
Nonetheless, c-Fos labeling has a number of limitations that can restrict its scope of use in some contexts (Hoffman and Lyo, 2002) . First, not all neurons that are known to be active by other techniques express c-Fos. Second, the temporal pattern of c-Fos expression makes it ineffective for parsing out short-lasting from long-lasting activity bursts. Third, c-Fos can only provide information on neurons which are activated, and not those which are inhibited. Fourth, this information can only be collected at a single time point in each animal, necessitating the use of multiple cohorts of animals for a time course study. Some groups, however, have developed transgenic mice that allow for the persistent tagging of activated neurons during a given time window by placing reporter genes under the control of the c-Fos promoter (Collaco and Geusz, 2003; Sanders et al., 2013) . Despite these limitations, c-Fos expression remains the most commonly used method for assessing neuronal activation, given its outlined advantages and the time limits and technical difficulties of other techniques such as electrophysiological recordings and imaging.
Several discrete areas were consistently activated by seizures regardless of the stage of epileptogenesis
Regardless of the stage of epileptogenesis and severity of seizures, neuronal c-Fos staining in the MSO model was consistently observed in several strongly interconnected areas, hereby defined as primary activation circuits, within the limbic system. Perhaps one of the best characterized such circuit is the entorhinal-hippocampal-entorhinal network, which facilitates the flow of signals via the following neuronal connections: layer II of the entorhinal cortex → granule cell layer of the dentate gyrus → CA3 → CA2 → CA1 → subiculum → layers V-VI of the entorhinal cortex → layer II of the entorhinal cortex (Witter et al., 1989) . Activation of this circuit by seizures has been reported in other models of MTLE, such as the systemic kainic acid (Popovici et al., 1990 ) and pilocarpine models (Harvey and Sloviter, 2005) and in models of amygdala kinding . Depth electrode EEG recordings from patients with MTLE also suggest that this circuit is preferentially involved during seizures (Spencer and Spencer, 1994) . Finally, a large number of cellular, molecular and chemical alterations have been demonstrated within this network in humans with MTLE and animal models of the disorder (reviewed in (O'Dell et al., 2012) ).
C-Fos staining was also consistently present, regardless of seizure severity, in other regions of the limbic system, particularly presubiculum, parasubiculum, lateral amygdaloid nucleus, perirhinal cortex, tenia tecta, anterior olfactory area, dorsal endopiriform nucleus, claustrum, and midline thalamic nuclei. Most of these regions communicate with the entorhinal-hippocampal circuit, or with each other, via unidirectional or reciprocal connections (Witter et al., 1989) . Some of the regions, particularly the amygdala, endopiriform nucleus, claustrum and midline thalamic nuclei, have been implicated in the pathophysiology of MTLE in humans and animal models. Many of these areas also express c-Fos after seizures in the systemic pilocarpine (Barone et al., 1993) and kainic acid models (Silveira et al., 2002) .
Amygdala is exquisitely sensitive to kindling in several species (Goddard et al., 1969; McIntyre et al., 1982) and is characterized by sclerosis, i.e. neuron loss and proliferation of astrocytes, in animal models and patients with MTLE (Hudson et al., 1993; Pitkanen et al., 1998) . Notably, spontaneous discharges occur in the lateral amygdala in human epilepsy specimens in vitro (Graebenitz et al., 2011) and also in epileptic, but not control animal specimens (Benini and Avoli, 2006) . Similar to the MSO-model, both the systemic kainic acid and pilocarpine models exhibit seizure-induced c-Fos staining in different regions of amygdala, such as the lateral and central nuclei (Barone et al., 1993; Silveira et al., 2002) . Interestingly, while the basolateral nucleus is often reported to [Rat C (pbs) ] is shown in C, H and I. There is intense staining of neurons in the anterior part of the periventricular thalamic nucleus (PVA), the central medial thalamic nucleus (CM), the intermediodorsal thalamic nucleus (IMD), the interanteromdial thalamic nucleus and the posterior part of the paraventricular thalamic nucleus (PVP) during early epileptogenesis and slightly less intense staining in the same areas during late epileptogenesis. Weak staining of very few cells were occasionally encountered in the PBS control (C, H, I). Abbreviations: 3 V, third ventricle; AVDM, anteroventral thalamic nucleus, dorsomedial part; f, fornix; fr, fasciculus retroflexus; LSV, lateral septal nucleus, ventral part; LV, lateral ventricle; PT, parathenial thalamic nucleus; sm, stria medullaris.
be stained in the kainic acid and pilocarpine models, this nucleus appears to be less consistently stained in the MSO-model.
The endopiriform nucleus also appears to have a role in seizure initiation. Injection of small quantities of proconvulsants into or near the rostral endopiriform nucleus (a.k.a. "area tempestas") triggers generalized tonic-clonic seizures (Piredda and Gale, 1985) whereas infusion of γ-vinyl GABA into the same area suppresses amygdala kindled seizures (Stevens et al., 1988) . The endopiriform nucleus is also consistently stained by C-Fos in the kainic acid model (Willoughby et al., 1997) .
The claustrum is located deep to the insular cortex in the human brain, and electrical stimulation of the claustrum leads to secondarily generalized seizures in the kindling model of MTLE (Mohapel et al., 2001) . Lesions of the claustrum delay the development of amygdala kindling and reduce the severity of kindled seizures from generalized to partial seizures (Wada and Kudo, 1997) . Moreover, magnetic resonance spectroscopy imaging has shown decreased N-acetylaspartate/creatine (NAA/Cr) ratios bilaterally in the claustrum in humans with MTLE vs. control subjects, suggestive of neuronal mitochondrial dysfunction in this area in MTLE.
Finally, studies have shown that the midline thalamic nuclei are important for seizure activity in the limbic system. Depth electrode EEG recordings of rats with kindled seizures and chronic limbic epilepsy show early seizure activity in the midline thalamus and degeneration of neurons in the medial dorsal, reuniens, and rhomboid nuclei (Bertram et al., 2001) . Thalamic neurons from these rats have changes in synaptically mediated and voltage-gated responses; moreover, lidocaine infusion into the midline thalamus shortens the after-discharge duration of the cells (Bertram et al., 2001 ) and infusion of the sodium channel blocker tetrodotoxin suppresses the limbic seizures (Sloan et al., 2011) . C-Fos staining of thalamic nuclei, including midline thalamus, also occurs in the pilocarpine (Barone et al., 1993) and kainic acid models (Beer et al., 1998) of MTLE.
4.3. Most areas were activated bilaterally; however, some areas were preferentially activated in the hemisphere that received MSO It is not surprising that most areas were activated bilaterally by the seizures even though MSO was infused unilaterally. Both hippocampi are extensively interconnected in the rat via several commissural pathways, thus ensuring efficient spread of seizures among limbic structures in both hemispheres (Blackstad, 1956 ). However, a small number of areas were preferentially activated ipsilateral to the MSO infusion, specifically the parasubiculum, layers II and V-VI of the entorhinal cortex, the lateral amygdala, the anterior olfactory area, and the tenia tecta. A hypothetical explanation for the unilateral preference is that these areas may not receive seizure input; rather they project to and activate the other, bilaterally involved areas. The unilaterally involved areas are therefore potentially regions of seizure initiation, rather than regions of seizure spread.
While future studies are necessary to establish whether these and other areas are critical for seizure initiation, published data provide some clues. The parasubiculum receives major inputs from glutamatergic cells of the CA1 and cholinergic cells of the medial septum as well as minor inputs from the subiculum, anterior thalamus and basolateral amygdala. The main efferents project to layer II of the entorhinal cortex, which in turn projects to the dentate granule cells and CA3 pyramidal neurons as the perforant pathway Witter, 1993, 1994; Funahashi and Stewart, 1997; Swanson and Cowan, 1979; Wouterlood et al., 1990) . Furthermore, presubicular neurons can generate theta frequency EEG activity, probably via membrane potential oscillations that are synchronized by local inhibitory inputs (Glasgow and Chapman, 2007) . Theta activity is important for modulation of hippocampal cognitive function, emotional behavior, stress and anxietymodalities that are often affected in MTLE (Pan and McNaughton, 2002; Richmond et al., 1999) . Hippocampal theta activity is also altered in human MTLE (Bettus et al., 2008) and in relevant animal models of the disease (Chauviere et al., 2009) . Finally, neurons in layers II and III of the parasubiculum, including parvalbumin-positive cells, are lost in animal models of MTLE, suggesting that local network changes involving the parasubiculum occur in epilepsy (Pitkanen et al., 1995; van Vliet et al., 2004) . The significance of the entorhinal cortex and amygdala for MTLE has already been discussed.
More extensive neuronal activation occurred late vs. early in epileptogenesis
The last observation is that seizure-induced activation extended beyond the limbic system in the later stages of the MSO model. The extended areas of activation include large portions of the neocortex, the nucleus of the stria terminalis, the mediodorsal thalamus, and the central nucleus of the amygdala. The widespread involvement of other brain areas, particularly the neocortex, is consistent with the more severe seizure phenotype seen late in epileptogenesis in the MSO model. A progressive worsening of the severity of seizures has been reported in other animal models (Norwood et al., 2010; Sloviter and Bumanglag, 2013) and in humans with MTLE (Pitkanen and Sutula, 2002) , suggesting that the development of MTLE (epileptogenesis) is a process of brain plasticity that may start focally, but eventually extends to involve multiple brain areas.
The current study provides novel and important information about regions of seizure involvement in the MSO model in a fairly unbiased fashion throughout the brain. However, the C-Fos approach cannot determine the exact onset and propagation of the seizures. Multiple depth EEG or single cell in vivo recordings carried out over days to weeks in the same animals, are required to address these issues. Nevertheless, the C-Fos approach is important because it can be used to guide the electrode placement in future electrophysiological recordings.
The role of GS in epilepsy
Our findings demonstrate that inhibition of astroglial GS focally in the entorhinal-hippocampal area of rats triggers a process of epileptogenesis characterized by gradual worsening of seizure severity and involvement of progressively larger neuronal populations over time. As mentioned above there is increasing evidence to suggest that GS is implicated in the causation of epilepsy due to its loss in patients with MTLE (Eid et al., 2004; van der Hel et al., 2005) and neocortical epilepsies (Steffens et al., 2005) , and the fact that inhibiting GS using MSO in rats results in recurrent seizures (Eid et al., 2008; Wang et al., 2009) , comorbid depressive behavior , and neuropathological features similar to human MTLE (Eid et al., 2008; Lauritzen et al., 2012) . Several other findings from humans and animals support the notion that a deficiency in GS is implicated in the causation of epilepsy. Humans with mutations in the GS gene develop epilepsy (Haberle et al., 2005) and heterozygous mutations of the astroglial GS gene in mice reduces the threshold to induced seizures (van Gassen et al., 2009) . Ingestion of domoic acid by California sea lions reduces astroglial GS and leads to epilepsy (Madl et al., 2014) and loss of astroglial GS occurs early in epileptogenesis in the hilus of the fascia dentate in the juvenile pilocarpine model of epilepsy (van der Hel et al., 2014) . However, the role of GS in epileptogenesis is complex. Studies have shown that hippocampal GS is temporarily upregulated in epileptogenesis in the kainic acid and kindling models of MTLE (Hammer et al., 2008; Sun et al., 2013) , and extremely low doses of MSO given during epileptogenesis may, in some cases, protect against development of epilepsy (Sun et al., 2013) . These seemingly discrepant features of GS in the causation of may be due to the model used and the anatomical distribution and timing of the GS perturbation. While further studies are needed to resolve these issues, the current findings clearly support the notion that inhibiting GS focally in the hippocampal formation induces epileptogenesis with worsening of seizures and involvement of progressively larger neuronal networks over time.
With respect to the current findings, future studies are needed to (a) to determine the parts of the network that are responsible for initiation, maintenance and spread of seizures respectively, (b) to characterize the causative mechanisms at play in the developing and developed network for seizure initiation, maintenance and spread, (c) to understand the vulnerability of the different parts of this network, and the network as a whole, to specific interventions at different points in the epileptogenic process, and (d) to determine whether there are any changes in the frequency, patterns and brain involvement of the seizures after the MSO-infusion pump has been discharged.
